Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachariah DeFilipp

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Blood Advances|December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsinStephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.
Blood Advances|March 30, 2018
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Jonathan U Peled, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are LessDavid F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Advances|February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysisYu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Blood Advances|April 19, 2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDAaron Etra, Najla El Jurdi, Nikolaos Katsivelos, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Blood Advances|May 26, 2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host diseaseMonzr M Al Malki, Kaitlyn London, Janna Baez, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Blood Advances|December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsinStephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.
Blood Advances|March 30, 2018
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Jonathan U Peled, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are LessDavid F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Advances|February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysisYu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Blood Advances|April 19, 2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDAaron Etra, Najla El Jurdi, Nikolaos Katsivelos, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2017
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic SyndromesAaron T Gerds, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Blood Advances|May 26, 2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host diseaseMonzr M Al Malki, Kaitlyn London, Janna Baez, et al.
Pageof 15